APITBIO is a platform-based biotech company dedicated to research and develop antibody-based innovative therapeutics. It was established by a group of experts in the field of antibody development through various cooperation with the industries, academia, research institutes, and hospitals to treat the unmet medical needs of consumers world-wide.
APITBIO
Category:
Venture
Main Business Area
APITBIO has monoclonal antibody pipelines, bispecific antibody pipelines, and a CAR-T pipeline under co-development.
| Contact Details | B1510 Munjeong Tera Tower 1, Songpa-daero 167 (Munjeong-dong), Songpa-gu, Seoul +82-2-6925-6570admin@apitbio.com |
|---|
